Rare diseases create a unique challenge for evidence generation. The number of patients is often small, diseases are heterogeneous, and clinical knowledge can be limited. Traditional clinical trials may struggle to recruit enough participants, follow patients for a sufficient period of time, or capture the complexity of disease progression in real life. For these… Continue reading Rare Disease Registries: How Much Data Is Enough? Balancing Scientific Rigor with Clinical Reality
Tag: Real World Evidence
From Wearables to Real-World Evidence: Are We Ready for Consumer-Generated Health Data?
The recent partnership between Oura and Eli Lilly has raised considerable attention across the healthcare industry. At first glance, it looks like another collaboration between a technology company and a pharmaceutical manufacturer. However, looking deeper, it signals a broader transformation that could introduce new aspects on how patients are monitored throughout their treatment journey. … Continue reading From Wearables to Real-World Evidence: Are We Ready for Consumer-Generated Health Data?
Do We Still Need Country-Specific Data?
In the European Union, data on racial or ethnic origin are classified as a “special category” under Article 9 of the GDPR, which generally prohibits their processing unless specific conditions are met, such as explicit consent or substantial public interest safeguards. As a result, several EU countries, including France, Germany, Denmark, and Sweden, do not… Continue reading Do We Still Need Country-Specific Data?
Real-World Evidence Without Data Ownership: How CROs Compete on Execution
The growing role of real-world evidence (RWE) across research, development, and decision-making has provided new opportunities for contract research organizations (CROs) operating in this space. However, the market of CROs delivering RWE is structurally unequal. With the notable exception organizations with proprietary data assets such as IQVIA, most CROs do not own large-scale proprietary healthcare… Continue reading Real-World Evidence Without Data Ownership: How CROs Compete on Execution
Using Real-World Data to Drive Precision Nutrition for Endurance Athletes
In Endurance Sports, Nutrition Is Not Advice, It’s an Intervention From Endurance Sport to Precision Nutrition Not many people who know me as a Real World Data professional in pharma are aware that I also run a side activity in precision nutrition for endurance athletes. This work began naturally, driven by my personal… Continue reading Using Real-World Data to Drive Precision Nutrition for Endurance Athletes